X @Bloomberg

Novo Nordisk is tapping the euro bond market with a multi-tranche sale expected to raise about €3.5 billion, as the Danish drugmaker seeks funding for its planned purchase of US biotech Akero Therapeutics https://t.co/6Ziuajw0uJ ...